Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Viracta Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 120K | Mar 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIRX | Viracta Therapeutics, Inc. | Mar 12, 2024 | 1 | $0 | 4 | Mar 13, 2024 | Chief Medical Officer |
VIRX | Viracta Therapeutics, Inc. | Aug 16, 2023 | 2 | $0 | 4 | Aug 18, 2023 | Chief Medical Officer |
VIRX | Viracta Therapeutics, Inc. | Aug 7, 2023 | 0 | $0 | 3 | Aug 16, 2023 | Chief Medical Officer |